PD-L1表达-话题@MedSci

#PD-L1表达#

28篇内容 | 787人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1941512, encodeId=e6591941512c4, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Journal for Immunotherapy of Cancer：罗成/党永军团队等发现L-5-羟基色氨酸可抑制PD-L1表达，发挥抗肿瘤效应, objectType=article, longId=730901, objectId=f8c7e3090132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8c7e3090132, replyNumber=0, likeNumber=27, createdTime=2023-04-07, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8c7e3090132, moduleTitle=Journal for Immunotherapy of Cancer：罗成/党永军团队等发现L-5-羟基色氨酸可抑制PD-L1表达，发挥抗肿瘤效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8c7e3090132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941513, encodeId=035c194151381, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值, objectType=article, longId=738658, objectId=9f99e3865805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f99e3865805, replyNumber=0, likeNumber=47, createdTime=2022-09-21, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f99e3865805, moduleTitle=JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f99e3865805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941511, encodeId=d7eb194151159, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Transl Lung Cancer Res: PD-L1表达水平与III期NSCLC患者使用durvalumab（德瓦鲁单抗）维持治疗疗效的关系, objectType=article, longId=295314, objectId=762829531471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=762829531471, replyNumber=0, likeNumber=49, createdTime=2022-05-04, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=762829531471, moduleTitle=Transl Lung Cancer Res: PD-L1表达水平与III期NSCLC患者使用durvalumab（德瓦鲁单抗）维持治疗疗效的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=762829531471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941510, encodeId=c4ec194151056, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Chest：支气管超声引导下针吸穿刺(EBUS-TBNA)获得的标本检测PD-L1表达同样可指导PD1抑制剂在晚期NSCLC患者中的应用, objectType=article, longId=292494, objectId=9f45292494ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f45292494ff, replyNumber=0, likeNumber=27, createdTime=2022-10-22, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f45292494ff, moduleTitle=Chest：支气管超声引导下针吸穿刺(EBUS-TBNA)获得的标本检测PD-L1表达同样可指导PD1抑制剂在晚期NSCLC患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f45292494ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941508, encodeId=cf92194150807, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Lancet Onocol：NSCLC脑转移的免疫治疗依赖PD-L1表达, objectType=article, longId=191515, objectId=c8b119151594, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8b119151594, replyNumber=0, likeNumber=28, createdTime=2020-04-21, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8b119151594, moduleTitle=Lancet Onocol：NSCLC脑转移的免疫治疗依赖PD-L1表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8b119151594)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941506, encodeId=76c8194150695, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响, objectType=article, longId=187601, objectId=3fc418e60132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fc418e60132, replyNumber=0, likeNumber=40, createdTime=2020-04-22, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fc418e60132, moduleTitle=J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fc418e60132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941507, encodeId=c569194150e82, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Brit J Cancer：PD-L2和PD-L1表达在食管癌患者中预后和临床意义, objectType=article, longId=190841, objectId=909219084165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=909219084165, replyNumber=0, likeNumber=53, createdTime=2021-02-02, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=909219084165, moduleTitle=Brit J Cancer：PD-L2和PD-L1表达在食管癌患者中预后和临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=909219084165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941509, encodeId=3a2a1941509ec, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Clini Cancer Res：PD-L1表达与三阴性乳腺癌新辅助化疗预后的相关性, objectType=article, longId=198067, objectId=a92519806e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a92519806e26, replyNumber=0, likeNumber=28, createdTime=2021-05-04, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a92519806e26, moduleTitle=Clini Cancer Res：PD-L1表达与三阴性乳腺癌新辅助化疗预后的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a92519806e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941502, encodeId=e66619415022e, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=实体瘤患者PD-L1表达与TMB、MSI的相关性研究, objectType=article, longId=168267, objectId=22fc16826e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22fc16826e29, replyNumber=0, likeNumber=43, createdTime=2019-10-11, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22fc16826e29, moduleTitle=实体瘤患者PD-L1表达与TMB、MSI的相关性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22fc16826e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941505, encodeId=00c61941505f1, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=K药治疗中国食管癌生存率翻倍无论PD-L1表达 ——解读KEYNOTE-181中国亚组分析结果, objectType=article, longId=180885, objectId=c2e718088544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2e718088544, replyNumber=0, likeNumber=38, createdTime=2020-08-26, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2e718088544, moduleTitle=K药治疗中国食管癌生存率翻倍无论PD-L1表达 ——解读KEYNOTE-181中国亚组分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2e718088544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941503, encodeId=efc919415033d, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, objectType=article, longId=179701, objectId=85981e970172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85981e970172, replyNumber=0, likeNumber=32, createdTime=2020-08-24, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85981e970172, moduleTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85981e970172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941504, encodeId=4ec4194150498, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=纳武利尤单抗食管癌首秀：无论PD-L1表达，患者总生存期获益均显著优于化疗, objectType=article, longId=180503, objectId=941618050315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=941618050315, replyNumber=0, likeNumber=45, createdTime=2020-02-04, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=941618050315, moduleTitle=纳武利尤单抗食管癌首秀：无论PD-L1表达，患者总生存期获益均显著优于化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=941618050315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941501, encodeId=0bf21941501b0, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Nat Commun：吸烟有益免疫治疗？反了！中国科学家发现香烟烟雾会诱导PD-L1表达，帮助癌细胞逃避免疫, objectType=article, longId=162996, objectId=f87a162996f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f87a162996f8, replyNumber=0, likeNumber=46, createdTime=2019-10-28, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f87a162996f8, moduleTitle=Nat Commun：吸烟有益免疫治疗？反了！中国科学家发现香烟烟雾会诱导PD-L1表达，帮助癌细胞逃避免疫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f87a162996f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941496, encodeId=10fe1941496c9, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=ASCO速递：PD-L1表达可预测膀胱癌免疫治疗疗效, objectType=article, longId=139899, objectId=92ae13989904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92ae13989904, replyNumber=0, likeNumber=38, createdTime=2018-12-13, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92ae13989904, moduleTitle=ASCO速递：PD-L1表达可预测膀胱癌免疫治疗疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92ae13989904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941500, encodeId=1445194150070, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=BMJ：PD-L1表达阴性患者 PD-1/PD-1抑制剂也能大幅延长生存期, objectType=article, longId=153166, objectId=251515316657, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=251515316657, replyNumber=0, likeNumber=0, createdTime=2019-02-10, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=251515316657, moduleTitle=BMJ：PD-L1表达阴性患者 PD-1/PD-1抑制剂也能大幅延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=251515316657)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941499, encodeId=473a194149909, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=NEJM：无论PD-L1表达水平帕博利珠单抗一线治疗转移性NSCLC鳞癌生存获益显著, objectType=article, longId=152644, objectId=1a4c15264424, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a4c15264424, replyNumber=0, likeNumber=32, createdTime=2019-03-15, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a4c15264424, moduleTitle=NEJM：无论PD-L1表达水平帕博利珠单抗一线治疗转移性NSCLC鳞癌生存获益显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a4c15264424)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941498, encodeId=72a01941498da, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=CLIN CANCER RES：MET致癌活化和JAK2失活会影响肺癌PD-L1表达, objectType=article, longId=150102, objectId=1ff11501029e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff11501029e, replyNumber=0, likeNumber=36, createdTime=2019-08-05, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff11501029e, moduleTitle=CLIN CANCER RES：MET致癌活化和JAK2失活会影响肺癌PD-L1表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff11501029e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941497, encodeId=3636194149e9c, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=JAMA Oncol：PD-L1表达可以预测免疫治疗疗效，PD-L1基因扩增呢？, objectType=article, longId=141402, objectId=21e01414028f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21e01414028f, replyNumber=0, likeNumber=30, createdTime=2018-07-08, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21e01414028f, moduleTitle=JAMA Oncol：PD-L1表达可以预测免疫治疗疗效，PD-L1基因扩增呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21e01414028f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941490, encodeId=52cd194149003, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=CLIN CANCER RES：黑色素瘤PD-L1表达：不同免疫组化抗体间的比较, objectType=article, longId=111292, objectId=a2f6111292d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2f6111292d7, replyNumber=0, likeNumber=32, createdTime=2018-01-18, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2f6111292d7, moduleTitle=CLIN CANCER RES：黑色素瘤PD-L1表达：不同免疫组化抗体间的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2f6111292d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1941494, encodeId=be7a1941494da, content=<a href='/topic/show?id=da8513930e7' target=_blank style='color:#2F92EE;'>#PD-L1表达#</a>, objectTitle=Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果, objectType=article, longId=125917, objectId=6df412591ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6df412591ef3, replyNumber=0, likeNumber=43, createdTime=2018-06-04, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6df412591ef3, moduleTitle=Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6df412591ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PD-L1表达

2020-05-29

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Journal for Immunotherapy of Cancer：罗成/党永军团队等发现L-5-羟基色氨酸可抑制PD-L1表达，发挥抗肿瘤效应

2023-04-07

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值

2022-09-21

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Transl Lung Cancer Res: PD-L1表达水平与III期NSCLC患者使用durvalumab（德瓦鲁单抗）维持治疗疗效的关系

2022-05-04

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Chest：支气管超声引导下针吸穿刺(EBUS-TBNA)获得的标本检测PD-L1表达同样可指导PD1抑制剂在晚期NSCLC患者中的应用

2022-10-22

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Lancet Onocol：NSCLC脑转移的免疫治疗依赖PD-L1表达

2020-04-21

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响

2020-04-22

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Brit J Cancer：PD-L2和PD-L1表达在食管癌患者中预后和临床意义

2021-02-02

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Clini Cancer Res：PD-L1表达与三阴性乳腺癌新辅助化疗预后的相关性

2021-05-04

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

实体瘤患者PD-L1表达与TMB、MSI的相关性研究

2019-10-11

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

K药治疗中国食管癌生存率翻倍无论PD-L1表达 ——解读KEYNOTE-181中国亚组分析结果

2020-08-26

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响

2020-08-24

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

纳武利尤单抗食管癌首秀：无论PD-L1表达，患者总生存期获益均显著优于化疗

2020-02-04

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Nat Commun：吸烟有益免疫治疗？反了！中国科学家发现香烟烟雾会诱导PD-L1表达，帮助癌细胞逃避免疫

2019-10-28

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

ASCO速递：PD-L1表达可预测膀胱癌免疫治疗疗效

2018-12-13

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

BMJ：PD-L1表达阴性患者 PD-1/PD-1抑制剂也能大幅延长生存期

2019-02-10

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

NEJM：无论PD-L1表达水平帕博利珠单抗一线治疗转移性NSCLC鳞癌生存获益显著

2019-03-15

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

CLIN CANCER RES：MET致癌活化和JAK2失活会影响肺癌PD-L1表达

2019-08-05

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

JAMA Oncol：PD-L1表达可以预测免疫治疗疗效，PD-L1基因扩增呢？

2018-07-08

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

CLIN CANCER RES：黑色素瘤PD-L1表达：不同免疫组化抗体间的比较

2018-01-18

lxg951 (审核中...)

前往app查看评论内容

#PD-L1表达#

Nature：CD4/6抑制剂通过增加PD-L1表达提高免疫检查点抑制剂的治疗效果

2018-06-04

科室
- - 订阅+
  - 更多科室
工具
服务